Results 121 to 130 of about 24,694 (138)

Influence of HAART on HIV-Related CNS Disease and Neuroinflammation

Journal of Neuropathology and Experimental Neurology, 2005
Peter Simmonds, J E Bell
exaly  

Pediatric Human Immunodeficiency Virus infection and cancer in the Highly Active Antiretroviral Treatment (HAART) era

Cancer Letters, 2014
Anita de Rossi, Carlo Giaquinto, Elena Chiappini   +2 more
exaly  

Effect of highly active antiretroviral therapy (HAART) on pharmacokinetics and pharmacodynamics of doxorubicin in patients with HIV-associated non-Hodgkin's lymphoma

Annals of Oncology, 2004
Giuseppe Toffoli, Emanuela Vaccher, Giuseppe Corona   +2 more
exaly  

Effect of Adherence to HAART on Virologic Outcome and on the Selection of Resistance-Conferring Mutations in NNRTI- or PI-Treated Patients

HIV Clinical Trials, 2007
D Kleinloog, Annapaola Callegaro, Franco Maggiolo   +2 more
exaly  

Highly active antiretroviral therapy (HAART) among HIV-infected drug users: a prospective cohort study of sexual risk and injecting behaviour

Addiction, 2006
Ronald Geskus
exaly  

AIDS‐associated cryptococcosis: a comparison of epidemiology, clinical features and outcome in the pre‐ and post‐HAART eras. Experience of a single centre in Italy

HIV Medicine, 2009
Fulvio Adorni, Giuseppe Giuliani, Spinello Antinori   +2 more
exaly  

HAART-related nephropathies in HIV-infected patients

Kidney International, 2005
Eric Daugas, Gary Hill
exaly  

Radiological Patterns in HIV-associated Pulmonary Tuberculosis: Comparison Between HAART-treated and Non-HAART-treated Patients

Clinical Radiology, 2003
Enrico Girardi, Fabrizio Palmieri, E Busi Rizzi   +2 more
exaly  

Determinants of survival following HIV-1 seroconversion after the introduction of HAART

Lancet, The, 2003
Patrizio Pezzotti, Janet Darbyshire, Abdel Babiker   +2 more
exaly  

HAART in HIV/AIDS Treatments: Future Trends

Infectious Disorders - Drug Targets, 2018
Nagendra Sastry Yarla, Ting-Ren Lu, Da-Yong Lu   +2 more
exaly